Sofosbuvir Plus Ribavirin Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Sofosbuvir (Primary) ; Ledipasvir/sofosbuvir; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Acronyms SWIFT-C
- 14 Jun 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 04 May 2017 Planned primary completion date changed from 9 Mar 2017 to 9 May 2017.